|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received March 29, 2006
Revised May 2, 2006
Accepted after revision August 22, 2006
1 University of Wisconsin, Department of Medicine
2 University of Wisconsin, Department of Medicine, and the MiddletonMemorial Veterans Hospital
3 University of Wisconsin, Dept. of Orthopeidcs and Rehabilitation
4 University of Wisconsin, Population Health Sciences
* To whom correspondence should be addressed. E-mail: axie{at}wisc.edu.
An important determinant of [H+] in the environment of the central chemoreceptors is cerebral blood flow. Accordingly we hypothesized that a reduction of brain perfusion and/or via a reduced cerebrovascular reactivity to CO2 would lead to hyperventilation and an increased ventilatory responsiveness to CO2. We used oral indomethacin to reduce the cerebrovascular reactivity to CO2 and tested the steady-state hypercapnic ventilatory response to CO2 in nine normal awake human subjects under normoxia and hyperoxia (50% O2). Ninety minutes after indomethacin ingestion, cerebral blood flow velocity (CBFV) decreased to 77% of the initial value; and the average slope of CBFV response to hypercapnoea was reduced to 31% of control in normoxia (1.92 vs. 0.59 cm-1 sec-1 mmHg-1, p<0.05) and 37% of control in hyperoxia (1.58 vs. 0.59 cm-1 sec-1 mmHg-1 , p<0.05). Concomitantly, indomethacin administration also caused 40-60% increases in the slope of the mean ventilatory respone to CO2 in both normoxia (1.27±0.31 vs 1.76±0.37 l min-1 mmHg-1, p<0.05) and hyperoxia (1.08±22 vs 1.79±0.37 l min-1 mmHg-1, p<0.05). These correlative findings are consistent with the conclusion that cerebro-vascular responsiveness to CO2 is an important determinant of eupneic ventilation and of hypercapnic ventilatory responsiveness in humans, primarily via its effects at the level of the cental chemoreceptors.
This article has been cited by other articles:
![]() |
S. Ogoh, N. Hayashi, M. Inagaki, P. N. Ainslie, and T. Miyamoto Interaction between the ventilatory and cerebrovascular responses to hypo- and hypercapnia at rest and during exercise J. Physiol., September 1, 2008; 586(17): 4327 - 4338. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Fan, J. D. Cotter, R. A. I. Lucas, K. Thomas, L. Wilson, and P. N. Ainslie Human cardiorespiratory and cerebrovascular function during severe passive hyperthermia: effects of mild hypohydration J Appl Physiol, August 1, 2008; 105(2): 433 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Steinback and M. J. Poulin Cardiovascular and cerebrovascular responses to acute isocapnic and poikilocapnic hypoxia in humans J Appl Physiol, February 1, 2008; 104(2): 482 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Peebles, L. Celi, K. McGrattan, C. Murrell, K. Thomas, and P. N. Ainslie Human cerebrovascular and ventilatory CO2 reactivity to end-tidal, arterial and internal jugular vein PCO2 J. Physiol., October 1, 2007; 584(1): 347 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Duffin Measuring the ventilatory response to hypoxia J. Physiol., October 1, 2007; 584(1): 285 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Ainslie, C. Murrell, K. Peebles, M. Swart, M. A. Skinner, M. J. A. Williams, and R. D. Taylor Early morning impairment in cerebral autoregulation and cerebrovascular CO2 reactivity in healthy humans: relation to endothelial function Exp Physiol, July 1, 2007; 92(4): 769 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Cummings, M. Swart, and P. N. Ainslie Morning attenuation in cerebrovascular CO2 reactivity in healthy humans is associated with a lowered cerebral oxygenation and an augmented ventilatory response to CO2 J Appl Physiol, May 1, 2007; 102(5): 1891 - 1898. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |